TACSTD2 and prostate carcinoma: Intriguingly, the RNA expression of ERBB2 was observed at levels similar to the highly expressed TROP2 and PSMA, suggesting that posttranscriptional factors may have an influence on the low level of HER2 expression observed in prostate cancer.